Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population

Table 3 Characteristics of colorectal cancer detected on screening

Characteristics	Colonoscopy (N = 16)	mSDC2 (N%)
		Positive (n = 14)	Negative (n = 2)
Gender
Male	9 (56.25)	8 (50.00)	1 (6.25)
Female	7 (43.75)	6 (37.50)	1 (6.25)
Age (yr)
40-49	3 (18.75)	2 (12.50)	1 (6.25)
50-59	5 (31.25)	5 (31.25)	0 (0)
60-69	7 (43.75)	7 (43.75)	0 (0)
70-79	1 (6.25)	0 (0)	1 (6.25)
TNM stage
0/I/II	8 (50.00)	6 (43.7)	2 (12.50)
III/IV	5 (31.25)	5 (31.25)	0 (0)
Unknown	3 (18.75)	3 (18.75)	0 (0)
Tumor location
Proximal	3 (18.75)	3 (18.75)	0 (0)
Distal	13 (81.25)	11 (68.75)	2 (12.50)
Tumor size (mm)
≤ 30	9 (56.25)	7 (43.75)	2 (12.50)
> 30	7 (43.75)	7 (43.75)	0 (0)
Dysplasia
Low	0 (0)	0 (0)	0 (0)
Median	12 (75.00)	12 (75.00)	0 (0)
High	4 (25.00)	2 (12.50)	2 (12.50)

mSDC: Syndecan-2 methylation.